Public HealthResidency ProgramBristol Myers Squibb is
a diversified specialty
biopharmaceutical company
whose mission is to discover,develop and deliver innovative
medicines that help patientsprevail over serious diseases.
Our medicines are helping
millions of patients aroundthe world in their fight against
cancer, cardiovascular disease,and immunologic disease.
As a biopharma leader, webelieve what sets us apart is ourcommitment to helping address
unmet medical needs of patientswith serious diseases and ourfocus on finding innovative
medicines to combat thosediseases.
This commitment to patients andunmet medical needs extends
to the Bristol Myers Squibb
Foundation, whose mission isto promote health equity andimprove outcomes of populations
disproportionately affected byserious diseases and conditions.

The Bristol-Myers Squibb Foundation’s (BMSF) approach to addressing health inequities
consists of strengthening healthcare worker capacity, integrating medical care andcommunity-based supportive services and mobilizing communities in the fight against
diseases. BMSF engages partners in government, academia and civil society in programs todevelop and test innovative approaches to improving health outcomes for poor and vulnerable
populations around the world.
Since 1999, BMSF has been working with partners in Africa to provide care and support forcommunities affected by HIV, tuberculosis and other non-communicable diseases. In 2016,
Global Cancer Disparities-Africa was launched to establish a Pan-African collaboration toimprove community awareness, data and care for unmet needs for prevalent and AIDS-related
cancers on the continent. Priority cancers include lung, cervical, pediatric cancers and blood
disorders and multiple myeloma.
Cardiovascular disease is the leading cause of death in the United States, inclusive of atrial
fibrillation, stroke, and venous thromboembolism. For specialty diseases such as rheumatoid
arthritis and multiple sclerosis, the failure to promptly diagnose and initiate therapy leads
to significant gaps of care for patients. Throughits U.S. Health Disparities in Cardiovascular andImmunologic Disease initiative, BMSF seeks toexpand grant making and partnerships to improveaccess, delivery and utilization of specialty care insafety net settings for patients with cardiovasculardisease and immunologic diseases.
The Public Health Residency program was createdin 2009 as a collaborative effort between theRutgers Institute for Pharmaceutical Industry
Fellowships Program of the Ernest Mario School of
Pharmacy (EMSOP) and BMSF. This unique PGY-2
pharmacy residency will prepare residents as publichealth practitioners with leadership skills anda variety of global and domestic experiences inresource-constrained settings.

Kiydra Harris, Public Health Resident 2016-2017,(second from left) with members of Mbeya HIV/AIDS Network in: Mbeya, Tanzania.

Building Comprehensive Models•M obilize communities to fight cancer,
cardiovascular and immunologic diseases•D evelop protocols to improve healthsystem delivery models• Strengthen and expand patient selfmanagement and community supportservices• I ntegrate and coordinate medical,
non-medical and policy efforts atthe community level• I mprove care for patients throughthe support of community-based
interdisciplinary teams•C reate collaboration care among
specialty and primary care•D evelop telemedicine capacity tosupport treatment decisions inrural areas

Feyikemi Osundina, Public Health Resident 20172018 presenting on vaccinations for Pharmacist
Month campaign at Kimberley Hospital, NorthernCape, South Africa

Public Health Residency
Program Overview
This 12-month residency is offered inconjunction with the Rutgers Institute for
Pharmaceutical Industry Fellowships Programof EMSOP and BMSF. The primary goal of theprogram is to improve health outcomes anddecrease health disparities through a systems
approach for non-communicable diseases.
The PharmD Resident will spend approximately
six months in southern Africa as part of theBMSF team with the Global Cancer DisparitiesAfrica program to help build capacity andprovide training to partner organizations.
Activities offer a wide range of opportunities
that build upon a pharmacy background andfurther develop diverse skill sets. Activities
depend on the current needs of projects andpartner organizations and may include:•T raining of pharmacy and other healthcare
professionals in disease state management
and pharmacotherapy•D eveloping protocols and proposals
leveraging the management of cancer into
existing HIV/AIDS platforms•H elping countries develop lung cancer
surveillance programs and registries to collectdata and make treatment recommendations• E ngaging community members andorganizations to help improve health outcomes• P roject implementation and management
at field sites

The Resident will then complete the remainderof the program in Lawrence Township, NewJersey, working with the U.S. Health Disparities
in Cardiovascular and Immunologic Disease
and other BMSF initiatives that address healthinequities in the United States. Activities dependon the current needs of projects and partnerorganizations and may include:•R esearching issues for the developmentof grant program strategies•D eveloping monitoring and evaluation

Diane Nguyen, Public Health Resident 2013-2014,(top row, far right) with members of the Johns
Hopkins Center for American Indian Healthin Chinle, Arizona.

indicators• P rovide expert review and technicalassistance for pharmacy-related issues•C onnecting project goals with policy andadvocacy advancement efforts• Reviewing grantee reports and learning
responsibilities as a grant makerAs adjunct faculty at the EMSOP, there will
be opportunities for the Resident to enhance
his/her experience by collaborating withfaculty through scholarship, publication,teaching and maintenance of clinical skills.
The Resident will also be invited to participate
in activities offered through the Rutgers
Pharmaceutical Industry Fellowships Program(http://pharmafellows.rutgers.edu), including
participation in the monthly Professional
Development Series, and will have access to alarge network of Fellowship alumni.

Priscilla Ko, Public Health Resident 2014-2015, (second fromleft) with the pharmacy department of Baylor International
Pediatrics AIDS Initiative in Mbabane, eSwatini.

Lynn Anyaele, Public Health Resident 2012-2013,(third from left) with members of Luthando
patient support group in Soweto, Johannesburg,South Africa.

Ishmael Qawiy, Public Health Resident 2015-2016, (fifth from right) with members from the Mathiwos Wondu Ethiopian Cancer Society (MWECS) in Addis Ababa, Ethiopia.

Application Management•R utgers will be recruiting at the ASHP Midyear Clinical Meeting•T o pre-schedule an interview at Midyear, please contact:
Emily Aboujaoude, PharmD
Clinical Professor, Pharmacy Practice & Administration
Rutgers, The State University of New Jersey
Email: emily.aboujaoude@pharmacy.rutgers.edu

Jennifer Torres
Bristol Myers Squibb Foundation
Email: jennifer.torres@bms.com

Please note that interested individuals should electronically submit a letter of intent,
a curriculum vitae, and three letters of recommendation after interviewing at Midyear
to Emily Aboujaoude, PharmD, and Jennifer Torres.
• Application materials may be submitted beginning December 14, 2020 until thedeadline of January 8, 2021.

Kya Norby, Public Heath Resident 2018-2019
with members of the Swaziland National Cancer
Registry in Mbabane, eSwatini.

Application Requirements•P harmD from an ACPE-accredited institution•C ompletion of a PGY-1 residency or equivalent experience is strongly preferred•C urriculum vitae

For more information:
Bristol Myers Squibb Foundation programs:
http://www.bms.com/foundation/•T hree letters of recommendation – applicants are encouraged to provide referencesfrom mentors in global experiences or resource-limited settings• A letter of intent (1-2 pages) addressing your interest in global/public health andlong-term plans•C andidates must be willing and able to relocate to southern Africa for 6 months.
Application materials will be accepted beginning December 14, 2020 until the deadline ofJanuary 8, 2021. Please send these to Emily Aboujaoude, PharmD, and Jennifer Torres.

Rutgers is an equal opportunity employer

www.bms.com